Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for hip dislocation in cerebral palsy
NCT03680196Completed
- Start
- Dec 2018
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in cerebral palsy (CP). Primary endpoint: Electromyography of hip adductor and spine muscles. Started Dec 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03680196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680196.